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Introduction
In 1832, Mc Ferlane first described a particular ty-
pe of fibrous neoplasm originated in the muscular apo-
neuroses, characterized by a biologic behaviour inter-
mediate between that of sarcomas and fibromas. In 1983,
Müller coined the term desmoid tumor (1,2). In 1923,
a case of extra-abdominal desmoid tumor was described
by Nichols (3).
Desmoid tumors - also called extra-abdominal or ag-
gressive fibromatosis – are rare fibromatous tumors of
fibroblast origin which involve muscular connective tis-
sue, muscular fascia and aponeuroses. They are locally
very aggressive and tend to infiltrate adjacent tissue even
it is that thought their clinical behaviour appears to be
quite different from that of sarcomas. In fact, desmoid
tumors are low-grade tumors which grow slowly but con-
stantly, do not metastasize either through lymph nodes
or through blood circulation; however, they have high
rates of local recurrence (4,5).
As the scarcity of cases limited the performing of stati-
stically significant perspective studies, desmoid tumors -
although more frequently diagnosed nowadays - still sti-
mulate the curiosity of the scientific community. Ove-
rall, desmoid tumors are reported to account for less than
0.03% of all neoplasms, with only 2-4 new cases per mil-
lion of inhabitants/year (6). They are fibroproliferative
disorders arising from musculoaponeurotic tissue and
their high local recurrence rates suggested a reactive etio-
logy; however, recently it has been shown that, even if
this tumor does not metastasize, a true neoplastic pro-
cess underlies fibroblast proliferation due to desmoid cell
clonality (7). 
Three main theories have been proposed to explain
the pathogenesis of desmoid tumors: mechanical
theory, endocrine theory, genetic theory.
According to the first theory, desmoid tumors may
be associated with trauma, stretch injuries of the abdo-
minal wall and especially enlarging pregnant uterus; the
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higher incidence of desmoid tumors in multipregnan-
cies and some cases observed after actinic therapy seem
to confirm this theory (8,9).
The endocrine theory is based on the fact that de-
smoid tumors are often associated with both endocrine
disorders and high estrogens levels. In fact, women of
fertile age who develop a desmoid tumor may have a pre-
disposition to estrogen predominance over progestero-
ne. In female, a direct relationship between tumor growth
rate and endogenous estrogen levels has been reported:
a significant increase in estradiol but not in progestero-
ne receptor concentrations in the tumor cell cytoplasm
has been observed; it suggests that desmoid tumor is hi-
ghly influenced by sex hormones (10). Positive answers
of patients undergoing antiestrogenic therapy (Ta-
moxifen) - strengthened by in vitro studies which have
shown the inhibition of desmoid cell proliferation - sup-
port this theory (11,12).
The genetic theory is supported by the evidence that
2% of desmoid tumors have a genetic origin. They may
appear due to APC mutation in patients with familial
adenomatous poliposis (FAP) or Gardner’s syndrome.
Indeed, the fact that 10% of desmoid tumors occur in
patients with FAP and 38% in those with Gardner’s syn-
drome, suggests a common genetic origin of both patho-
logies. This theory is supported by the presence of tri-
somy 8 and 20 in desmoid cells (13-15). An autosomal
dominant syndrome of hereditary desmoid disease
(HDD) due to mutation at codon 1924 of the APC ge-
ne has been reported (16). However, in most cases, the
etiology remains unknown (10). The neoplastic tran-
sformation of desmoid tumors into sarcoma is extremely
rare; Literature reports only 5 cases (11,17,18).
Nodular fasciitis, which on the contrary is a benign,
rapidly growing soft tissue tumor characterized by fi-
broblastic and miofibroblastic proliferation of uncertain
etiology has a similar clinical presentation. Its macro-
scopic appearance and clinical behaviour make pre-ope-
rative diagnosis extremely difficult because of its ability
to simulate a malignant process (19-21). Nodular fasciitis
was first described by Konwaler et al. in 1955 (22), as
a pseudosarcomatous fasciitis with a rich mitotic acti-
vity. In Literature the terminology for this type of lesion
may be: proliferative fasciitis, infiltrating fasciitis and
pseudosarcomatous fibromatosis (23).
It is a benign rapidly growing reactive fibroblastic pro-
liferation of uncertain etiology, which may occur conse-
quently to a non-specific inflammatory process, although
trauma has also been implicated. More recently, clonal ch-
romosomal abnormalities have been reported in a small
number of cases, suggesting that at least some cases of no-
dular fasciitis may represent a clonal myofibroblastic tu-
mor (24,25). Nodular fasciitis may occur in three main
forms according to the location of the lesion: 1) the sub-
cutaneous form is more frequently observed and presents
as a small subcutaneous defined nodule; 2) the intramu-
scular form is rare, about 10% of all the fasciitis, has a lar-
ger size and infiltrates; 3) the fascial form with irregular den-
dritic margins originates from the superficial fascia. 
Clinical observation, study and surgical treatment of
4 patients with solid musculofascial neoformations – of
which 3 turned out to be desmoid tumors (aggressive
fibromatosis) – gave us the possibility to critically eva-
luate different problems related to diagnosis and treat-
ment of these patients.
Case reports
Four patients (3 females and 1 male) were observed in the Sur-
gical Science Department, “Sapienza” University of Rome, over the
last two years with proliferative intramuscular neoformations (Ta-
ble 1), having quite similar clinical characteristics; the final diagno-
sis was aggressive fibromatosis (desmoid tumors) in 3 patients and
nodular fasciitis in 1 of them. First two cases concerned two young
women (FF, 28-year old and CG, 36 year-old), both with recent pre-
gnancies in their history who reported a rapidly growing mass in the
rectus abdominis muscle; they noticed the mass for the first time 6-
8 months before. The first case was approximately 4 cm in diame-
ter and it was located at the left side of the rectus abdominis mu-
scle; the second one, was located at the right side of the rectus ab-
dominis muscle and it was about 7 cm in diameter.
In both patients, physical examination revealed an irregular,
smooth-surfaced mass of hard parenchymatous consistency with qui-
te well defined margins; it was fixed to the muscles and followed mu-
scle contraction; it was almost asymptomatic and only slightly pain-
ful upon palpation. In both cases, echographic examination showed
an inhomogeneous mainly hypoechogenic echostructure with polycy-
clic and irregular margins and minimal peripheral vascularization. An
MRI was performed on the first patient and a CT scan on the second
one. Both examinations showed the integrity of adjacent structures
and confirmed both tumor size and its perilesional vascularization.
The first patient underwent an echoguided tru-cut needle bio-
psy: despite the small quantity of tissue collected, extemporary hi-
stological examination revealed a lesion made of fibrous tissue com-
patible with fibromatosis. Definite diagnosis was achieved by final
histologic examination. Pre-operative biopsy was not performed on
the second patient because of benign radiologic features of the le-
sion (well-defined margins and perilesional vascularization). Both
patients underwent surgical intervention: a pararectal incision was
performed (on the left and on the right side respectively) and the
mass was excised in toto with most of rectus abdominis muscle and
its aponeurosis trying to obtain clear surgical margins. As a clear clea-
vage plane was achieved in both patients, it was not necessary to open
the peritoneum. Wall repair was performed using a double thick-
ness of Marlex mesh cut to appropriate dimensions that was sutu-
red to musculoaponeurotic structures using prolene sutures. Posto-
perative course was uneventful in both patients. At present - 2 years
after surgery – there is no evidence of recurrence. 
Third case concerned a 42-year-old man, with no major patho-
logy at his past medical history who, over the past 4 months, noti-
ced the onset of a hard and elastic lump of approximately 3 cm in
maximum diameter in the medial third of the right thigh of qua-
driceps femoris muscle. Ecographic examination revealed a solid, en-
capsulated lump of 33 mm in maximum diameter in the quadrice-
ps femoris muscle compressing the surrounding area with no evi-
dence of neoplastic infiltration. Power-doppler did not reveal in-
tralesional vascular spots.
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TABLE 1 - PATIENTS.
N Patient Sex Age Location / Muscle cm Vascularization Histology
1 F. F. F 28 Left Rectus abdominis 4 x 1,6 Perilesional Desmoid tumor
2 C. G. F 36 Right Rectus abdominis 7 x 5 Perilesional Desmoid tumor
3 G. F. M 43 Right femoral quadriceps 3 x 1,7 Perilesional Desmoid tumor
4 C. A. F 30 Adduttor magnum 3 x 3 Intralesional Nodular fasciitis
Fig. 1 - A) CT scan with intra-venous contrast injection showing the mass located in the left rectus abdominis wall. B) CT-scan showing the mass located inside
the right rectus abdominis muscle. C) CT scan of the right thigh: the lesion appears to be very vascularizated.
Fig. 2 - A-B) Intraoperative picture showing the integrity of the
peritoneal cavity. C) Intraoperative picture: partial wall repair
by a double layer of overlapped Marlex mesh. D) Intraopera-
tive aspect of the lesion – the sartorius muscle has been di-
varicated downwards.
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CT scan - performed before and after intravenous contrast injec-
tion - showed a round, hypo-isodense nonenhancing lump with well-
defined margins measuring about 1,8 x 3,5 cm in the quadriceps fe-
moris muscle. The patient refused to undergo needle biopsy and,
indeed, biopsy was not required to plan surgical intervention because
of small tumor size. Surgical intervention removed the mass by making
attention to achieve, where possible, clear surgical margins. Cut sec-
tion of the operative specimen revealed a whitish pseudocapsulated
oval-shaped mass of hard elastic consistency.
Fourth case concerned a 30-year-old woman. Over the past 1
month she noticed a nodular rapidly growing lesion located deeper
in the muscles of the proximal third in the medial region of the right
thigh. This roundly-shaped lesion, measuring approximatively 3 cm
in diameter, was fairly attached to the surrounding tissues and had a
hard parenchymatous consistency. This nonpulsating, painless but sli-
ghtly painful mass had almost regular but not well-definable multi-
lobulated margins. The overlying skin showed no sign of phlogosis.
Echographic evaluation revealed a solid lesion, but it did not provide
any further information about it. CT-scan – performed after and befo-
re intravenous contrast injection - revealed a roundly-shaped hypo-
dense lesion in the middle third of the adductor magnus muscle of
the right thigh; after intravenous contrast injection, CT showed a re-
markable increase in lesion density and a small hypodense central area.
This mass appeared to have well-defined margins and a regular sha-
pe referable to the neoformation arising from the right adductor ma-
gnus muscle. Radiologist suggested an MRI for further evaluation. The
MRI – performed before and after intravenous contrast injection using
SE and SPIR sequence in axial and coronal planes – confirmed that
the lesion observed in the adductor magnus muscle extended ap-
proximatively 3 cm craniocaudally. On SE T1-weighted images the
lesion appeared isointense, while it was markedly hyperintense after
contrast injection. The rich vascularization of the lesion and its well-
defined margins lead us to a pre-operative diagnosis of soft tissue le-
sion, probably benign. We couldn’t exclude its angiomatous nature.
Because of the rich vascularization and radiologic features of benignity,
pre-operative needle biopsy was not performed. Surgery was perfor-
med to remove the mass that was almost completely indovated within
the adductor magnus muscle; the sartorius muscle was isolated and
cut and the underlying lesion was identified and excised. A wide area
of muscular tissue from around the lesion was removed in order to
achieve clear surgical margins. This tissue appeared to be adherent to
the lesion so as that a neoplastic infiltration was suspected. Cut sec-
tion of the lesion revealed a solid, grey- lardaceous, encapsulated mass.
Postoperative course was uneventful and the patient recovered rapidly
with no functional deficit. At present – more than one year after sur-
gery – there is no evidence of recurrence.
Histologic examination – that was similar in the first three pa-
tients – showed a proliferation of fusiform cells arranged in long fa-
scicles with infiltrative growth pattern involving the perilesional ske-
letal muscular tissue. There was strong evidence of atrophic pheno-
menon due to compression. Histology was compatible with the dia-
gnosis of desmoid tumor (extra-abdominal aggressive fibromatosis).
On the contrary, in the fourth patient histologic examination
revealed a sarcomatous-like lesion characterized by short fascicles of
fusiform and star-like cells arranged in a storiform growth pattern
and cheloid-like central areas surrounded by several neoformed ca-
pillary vessels associated with haemorrhagic extravasations and in-
flammatory lymphocytic infiltration. Histology was compatible with
the diagnosis of nodular fasciitis.
Differential diagnosis between desmoid tumor and nodular fa-
sciitis is based upon the greater size and mainly infiltrative growth
pattern of the first lesion in comparison with the second one. De-
smoid tumor is characterized by a proliferation of fusiform cells ar-
ranged in long fascicles, while nodular fasciitis is characterized by
short fascicles interlaced in a storiform-like pattern. Nodular fascii-
tis is also characterized by huge haemorrhagic extravasations and in-
flammatory lymphocytic infiltration, not so evident in desmoid tu-
mor. Mitoses - which occur in both tumors - are usually much mo-
re numerous in nodular fasciitis.
Discussion
Musculo-aponeurotic lesions, expecially extra-ab-
dominal ones, sometimes have very similar clinical and
semeiologic features characterized by difficulty in dia-
gnosis and doubts on therapeutic choice. 
Both pre-operative needle aspiration biopsy and ex-
temporary histologic examination are not always able to
make a definite diagnosis. In fact, only the whole cy-
toarchitecture of the tumor provides elements for a de-
finite diagnosis. Several therapeutic options have been
proposed to treat desmoid tumors: surgical excision, ra-
diotherapy, adjuvant radiotherapy, chemotherapy, po-
lichemotherapy, the use of antiestrogens and FANS (26-
29).
We discussed the opportunity to perform either a
FNA or a pre-operative biopsy to better plan surgical in-
tervention. Indeed, compartmental resection – when it
is possible - should be the therapy of choice for sarco-
ma; on the contrary, it would be undoubtly excessive in
the treatment of benign lesions - such as pseudosarco-
matous nodular fasciitis – as well as of low-grade tumor
– such as desmoid tumors, that have a clinical behaviour
completely different from that of sarcomas, do not me-
tastasize and, at least, can recur locally - . However, a
wide or, at least, a marginal excision of the lesion should
be performed trying to avoid intracapsular excisions in
order to lower the risk of local recurrence due to tissue
residual. It is believed that desmoid tumors rarely tran-
sform into sarcoma: literature reports only 5 cases of ma-
lignant degeneration (10, 17,18), even if the true inci-
dence could be likely to be underestimated, because the
lack of systematically oriented investigations.
From a technical point of view, the only raccoman-
dation concerning the exeresis of perilesional healthy tis-
sue of legs is to respect adjacent vascular and nervous
structures. Abdominal wall lesions with no evidence of
infiltration can be better treated by surgical excision in-
volving only the peritoneal wall. It may allow the use of
polypropylene meshes which represent the most ap-
propriate solution to the problem of abdominal wall re-
pair because of their characteristics: stability over time,
plasticity, biological inertia, resistance to infection, pos-
sibility to be easily moulded and to double thickness in
order to provide greater support (30).
Among the international community, the advanta-
geousness of performing either demolitive resections (31)
or radiotherapy (32) – as proposed by some Authors -
is still an open issue.
Adjuvant radiotherapy seems to be the most effecti-
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ve treatment to prevent recurrence of desmoid tumors
after radical, marginal and even intralesional surgery. Ob-
viously, recurrence rate depends on the kind of surgical
resection performed, being lower in case of radical sur-
gery (33). Adjuvant radiotherapy following non radical
surgery should lower the chances of local recurrence (34).
On the contrary, other Authors believe that adjuvant ra-
diotherapy associated to surgery doES not reduce re-
currence rate but, indeed, it may double it (6)6; anyway
we have no experience about it. 
Some Authors – considering desmoid tumors are ju-
st locally aggressive and have a long-term good prognosis
- suggest a less aggressive attitude: if radical surgery ri-
sks to be mutilant or to leave severe effects, radiotherapy
(50-60 Gy) or chemotherapy with Doxorubicin and Da-
carbazine may control the neoplasm for a long time (28-
35). Tamoxifene seems also to control the tumor, as it
has been shown by in vitro studies of inhibition of de-
smoid cell proliferation (11,12). From a diagnostic point
of view, pseudosarcomatous nodular fasciitis is less ag-
gressive than desmoid tumors; in our experience the only
difference concerned the size and the kind of vasculari-
zation of the lesion, which was intralesional only in this
case. Local recurrence might therefore be due to dia-
gnostic mistakes or incomplete exeresis; however, a re-
liable pre-operative diagnosis is seldom available, the-
refore the most correct surgical behaviour is similar to
that of desmoid tumors.
Pseudosarcomatous nodular fasciitis and desmoid tu-
mors have very similar clinical characteristics. Surgical
excision of nodular fasciitis lesions is usually curative;
on the contrary, desmoid tumors – despite they are low
aggressive tumors – tend to recur locally. Therefore, pri-
mary surgery with negative surgical margins is the mo-
st successful treatment method, trying to avoid muti-
lant surgery and using chemotherapy, radiotherapy and
hormono-therapic treatments to lower the chances of re-
currence.
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